Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

A proof-of-concept study of quantitative tumor perfusion imaging with 82Rb PET/CT in Prostate Cancer

Mads Jochumsen, Lars Tolbod, Bodil Ginnerup Pedersen, Michael Borre, Jorgen Frokiaer, Kirsten Bouchelouche and Jens Sorensen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1473;
Mads Jochumsen
1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Tolbod
1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bodil Ginnerup Pedersen
2Department of Radiology Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Borre
3Department of Urology Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorgen Frokiaer
1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten Bouchelouche
1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Sorensen
1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 1473

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Mads Jochumsen1,
  2. Lars Tolbod1,
  3. Bodil Ginnerup Pedersen2,
  4. Michael Borre3,
  5. Jorgen Frokiaer1,
  6. Kirsten Bouchelouche1 and
  7. Jens Sorensen1
  1. 1Department of Nuclear Medicine & PET Centre Aarhus University Hospital Aarhus Denmark
  2. 2Department of Radiology Aarhus University Hospital Aarhus Denmark
  3. 3Department of Urology Aarhus University Hospital Aarhus Denmark

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to April 2025

AbstractFullPdf
May 2018200
Jun 20181700
Jul 20181300
Aug 2018500
Sep 2018300
Oct 2018300
Nov 2018300
Dec 2018300
Jan 2019900
Feb 2019500
Mar 2019900
Apr 2019900
May 2019800
Jun 2019300
Jul 2019200
Aug 2019400
Sep 2019800
Oct 2019200
Nov 2019900
Dec 2019200
Jan 2020100
Feb 2020400
Mar 2020900
Apr 2020100
May 2020200
Jun 2020500
Jul 2020600
Aug 2020100
Dec 2020200
Jan 2021200
Feb 2021800
Mar 2021600
Apr 2021800
May 2021500
Jun 2021400
Jul 2021400
Aug 2021700
Sep 2021800
Oct 2021100
Nov 2021200
Dec 2021700
Jan 2022500
Feb 2022400
Mar 2022200
Apr 20221300
May 2022500
Jun 2022300
Jul 2022300
Aug 2022100
Oct 2022200
Nov 2022100
Dec 2022100
Jan 2023100
Mar 2023300
Apr 2023400
May 2023100
Jun 2023200
Jul 2023100
Aug 2023200
Sep 2023100
Oct 2023300
Nov 2023400
Dec 2023400
Jan 2024500
Feb 2024100
Mar 2024300
Apr 2024100
May 2024700
Jun 2024400
Jul 2024100
Aug 2024400
Sep 2024600
Oct 2024600
Nov 2024400
Dec 2024100
Jan 2025300
Feb 2025400
Mar 2025400
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A proof-of-concept study of quantitative tumor perfusion imaging with 82Rb PET/CT in Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A proof-of-concept study of quantitative tumor perfusion imaging with 82Rb PET/CT in Prostate Cancer
Mads Jochumsen, Lars Tolbod, Bodil Ginnerup Pedersen, Michael Borre, Jorgen Frokiaer, Kirsten Bouchelouche, Jens Sorensen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1473;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A proof-of-concept study of quantitative tumor perfusion imaging with 82Rb PET/CT in Prostate Cancer
Mads Jochumsen, Lars Tolbod, Bodil Ginnerup Pedersen, Michael Borre, Jorgen Frokiaer, Kirsten Bouchelouche, Jens Sorensen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1473;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Prostate Posters

  • Clinical Experience with 18F-fluciclovine (Axumin) in Prostate Cancer Patients with a Rising PSA After Primary Treatment
  • Hematologic safety in patients treated with Radium - 223 in Fundación Santa Fe de Bogota, Colombia , between 2014 - 2017
  • Decision making in radiation oncology based on 68Ga-PSMA-11 PET/CT for primary and recurrent prostate cancer
Show more Prostate Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire